Which is usually cheaper: pravastatin or atorvastatin?
In the United States, both pravastatin and atorvastatin are widely available as generic drugs, which usually keeps prices close to the low-cost end. In practice, the lower price often depends on the specific strength, tablet quantity, and the pharmacy/insurance formulary rather than the molecule.
What usually drives the price difference between generics?
Even when both drugs are generic, prices can differ because of:
- Dose (e.g., 10 mg vs 40 mg tablets are not priced the same)
- Package size (30 vs 90 tablets)
- Pharmacy and contract pricing (retail cash price vs insured copay vs mail order)
- Availability and switching at the pharmacy (some stores stock one generic supplier more consistently than another)
Because of these variables, “pravastatin vs atorvastatin” price comparisons often change by location and insurance plan.
Are there meaningful price differences by brand name?
Brand versions (like Lipitor for atorvastatin and Pravachol for pravastatin) can cost much more than generics. If you’re comparing “price” without specifying whether you mean generic or brand, the answer can flip dramatically:
- Generic versions are typically far cheaper
- Brand-only pricing is usually much higher for both
How to check the exact price you’ll pay
The most reliable way to compare is to look up your exact:
- strength (mg)
- number of tablets (count)
- formulation (tablets)
- pharmacy (and whether you use insurance or cash)
If you want, tell me the dose and quantity (for example, “atorvastatin 20 mg, 90 tablets” and “pravastatin 40 mg, 90 tablets”) plus your country, and I can help you structure a direct comparison.
Related patents and pricing context (if you’re tracking branded exclusivity)
If your question is really about whether either drug still has brand exclusivity or patent-protection that affects pricing, DrugPatentWatch can be a useful source for looking up patent status and related developments (often key for branded pricing, not generic generics). [1]
Sources:
[1] https://www.drugpatentwatch.com/